Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
UBS
Citi
Dow
Accenture
Cantor Fitzgerald
Daiichi Sankyo
Medtronic

Generated: June 17, 2018

DrugPatentWatch Database Preview

FLURAZEPAM HYDROCHLORIDE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Flurazepam Hydrochloride patents expire, and what generic alternatives are available?

Flurazepam Hydrochloride is a drug marketed by Aurolife Pharma Llc, Halsey, Hikma Intl Pharms, Hikma Pharms, Mylan Pharms Inc, Par Pharm, Purepac Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, Warner Chilcott, and Watson Labs. and is included in twenty-two NDAs.

The generic ingredient in FLURAZEPAM HYDROCHLORIDE is flurazepam hydrochloride. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the flurazepam hydrochloride profile page.
Drug patent expirations by year for FLURAZEPAM HYDROCHLORIDE
Pharmacology for FLURAZEPAM HYDROCHLORIDE
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for FLURAZEPAM HYDROCHLORIDE
Synonyms for FLURAZEPAM HYDROCHLORIDE
(S)-N-((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxo-tetrahydropyrimidin-1(2H)-yl)butanamide
1172-18-5
1172-18-5 (di-hydrochloride)
17617-23-1
17617-23-1 (Parent)
191044-EP2275420A1
191044-EP2280008A2
2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-, 1,3-dihydro-, dihydrochloride
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-,1,3-dihydro-, dihydrochloride
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-
2H-1,4-Benzodiazepin-2-one, 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-
2H-1,4-Benzodiazepin-2-one,7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-, dihydrochloride
36105-20-1 (mono-hydrochloride)
5-24-04-00322 (Beilstein Handbook Reference)
617F231
7-chloranyl-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one, dihydrochloride
7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-1,4-benzodiazepin-2(3H)-one
7-Chloro-1-(2-(diethylamino)ethyl)-5-(2-fluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one
7-Chloro-1-(2-(diethylamino)ethyl)-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one dihydrochloride
7-chloro-1-(2-diethylaminoethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
7-chloro-1-(2-diethylaminoethyl)-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one dihydrochloride
7-Chloro-1-(diethylamino)ethyl-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2(1H)-one dihydrochloride
7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-Chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one #
7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one
7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one
7-Chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
756RDM536M
A812156
AC1L1FU2
AC1L23TS
AKOS015889971
AN-5395
Benozil
BRN 0767925
C-21488
CAS-17617-23-1
CC-28512
CHEBI:5128
CHEBI:5129
CHEMBL968
D00329
D00695
D08XFV
Dalmadorm
Dalmadorm (TN)
Dalmane
Dalmane (TN)
Dalmane-R
Dalmate
DB00690
DEA No. 2767
DSSTox_CID_3071
DSSTox_GSID_23071
DSSTox_RID_76863
DTXSID1023071
DTXSID3025334
EINECS 214-630-0
EINECS 241-591-7
Felison
Felmane
Flunox
flurazepam
Flurazepam (JAN/INN)
Flurazepam (JP15/INN)
Flurazepam [INN:BAN:JAN]
Flurazepam 0.1 mg/ml in Methanol
Flurazepam 1.0 mg/ml in Methanol
Flurazepam dihydrochloride
FLURAZEPAM DIHYDROCHLORIDE (SEE ALSO FLURAZEPAM (17617-23-1))
flurazepam dihydrochloride--dea*schedule iv item
Flurazepam dihydrochloride, drug standard, 1.0 mg/mL in methanol
Flurazepam dihydrochloride, solid
Flurazepam HCL
Flurazepam hydrochloride (USP)
Flurazepam hydrochloride [USAN:JAN]
Flurazepam hydrochloride [USAN:USP:JAN]
Flurazepam hydrochloride, United States Pharmacopeia (USP) Reference Standard
Flurazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Flurazepam-D4 solution, 100 mug/mL in methanol, certified reference material
Flurazepamum
Flurazepamum [INN-Latin]
FT-0603548
FT-0630442
GTPL7188
HE069336
HSDB 3085
ID 480
IHP475989U
Insumin
Insumin (TN)
Insumin dihydrochloride
Linzac
LS-34188
LS-595
Lunipax
Natam
NCGC00164573-01
NCGC00164573-02
Noctosom
NSC-78559
Paxane
Ro 5-6901
Ro 56901/3
Ro-5-6901
Ro-5-6901/3
Ro-56901
SAADBVWGJQAEFS-UHFFFAOYSA-N
SCHEMBL29792
SCHEMBL29793
Somlan
Somnol
Stauroderm
Tox21_112201
Tox21_112201_1
UNII-756RDM536M
UNII-IHP475989U
Valdorm
W-108568
ZINC537752

US Patents and Regulatory Information for FLURAZEPAM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurolife Pharma Llc FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071717-002 Jul 31, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Usl Pharma FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 070563-001 Jul 9, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 072369-001 Mar 30, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 070345-002 Nov 27, 1985 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Teva
McKesson
Healthtrust
Farmers Insurance
Daiichi Sankyo
Johnson and Johnson
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.